Please login to the form below

Not currently logged in
Email:
Password:

Norway

This page shows the latest Norway news and features for those working in and with pharma, biotech and healthcare.

IQVIA and partners set up cancer ‘data hub’ to speed up research

IQVIA and partners set up cancer ‘data hub’ to speed up research

The study showed that the UK performed worse than Australia, Canada, Denmark, Ireland, New Zealand and Norway in terms of cancer survival rates. .

Latest news

More from news
Approximately 1 fully matching, plus 124 partially matching documents found.

Latest Intelligence

  • The case for a second Brexit referendum: “We need the informed consent of the people” The case for a second Brexit referendum: “We need the informed consent of the people”

    As many in the pharma industry know, the EEA allows Norway, Iceland and Liechtenstein to be part of the EMA and gain access to the new medicines at the same time.

  • The tipping point The tipping point

    National policy mandates to switch from the originator to biosimilars, as has been the case in Norway, have resulted in rapid and almost complete biosimilar market penetration.

  • Building a bright future Building a bright future

    We have many examples where small molecule and biosimilars have improved uptake such as the case of infliximab in Norway, which was supported by the government that sponsored clinical trials showing

  • Pharma deals continue to slide Pharma deals continue to slide

    For example this month, Karo Pharma, Sweden acquired Weifa, Norway for $163m for product and territory complementarity.

  • 2016: The year when deal-makers took stock? 2016: The year when deal-makers took stock?

    product. (According to the journal Biosimilar Development the price of EPO in Norway was sold at an 83% discount from the original price.). ... The rate of uptake of biosimilars in Norway is exceptional, but the upward trend in other countries is still

More from intelligence
Approximately 0 fully matching, plus 15 partially matching documents found.

Latest appointments

  • Gilead Sciences appoints general manager, Canada Gilead Sciences appoints general manager, Canada

    Brysting was most recently general manager of Gilead Nordics, comprising the company's businesses in Sweden, Norway, Denmark, Finland and Iceland.

  • Targovax appoints chief financial officer Targovax appoints chief financial officer

    Dr Wiklund joins the Oslo, Norway-based immuno-oncology specialist from Aker Biomarine Antarctic, where he served as director of product innovation.

  • Algeta execs join Targovax Algeta execs join Targovax

    Anna-Kirsti Aksnes and Tina Madsen join the firm. Norway's Targovax has added to its senior team with the appointment of two executives from Algeta.

  • Anker Lundemose appointed CEO of Bionor Pharma Anker Lundemose appointed CEO of Bionor Pharma

    The Norway-based biotech, which is focused on peptide-based vaccines for HIV, said Dr Lundemose will take over the role from March 1, when his predecessor Steen Krøyer becomes deputy

  • Matt Regan named AbbVie’s general manager in UK Matt Regan named AbbVie’s general manager in UK

    Was formerly general manager of Abbott in Norway. AbbVie, the new independent biopharma spin-out from Abbott, has appointed Matt Regan as general manager of its UK business. ... Regan was formerly general manager for Abbott in Norway and will now oversee

More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Four Health

Beautiful things happen when you put the right ingredients together. It’s the reason that we mix behaviour change experts with...

Latest intelligence

Alzheimers incidence
A roadmap to the successful treatment of Alzheimer’s disease
Building on past research to learn more about the disease and how to treat it...
Article: Like, Like, Like: Harnessing the power of social media insights
...
Its Know Your Numbers week
Do you know yours?...

Infographics